Urologists appear more likely than other specialists to inappropriately treat uncomplicated cystitis, according to study findings.
Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use.
The increased risk for several urinary tract problems among women diagnosed with endometrial cancer varies by age and race or ethnicity, a study found.
In the CRL, the FDA stated that the application could not be approved in its present form and that an additional clinical trial would be required.
Researchers assessed whether there is an association between urinary tract infection incidence and international travel.
Women with rUTIs have a gut microbiome that is significantly depleted in microbial richness and butyrate-producing bacteria.
In this meta-analysis, researchers assessed whether patient race is a proxy for other factors in predictive models that show an association between race and urinary tract infection risk.
The approvals were based on data from pediatric trials evaluating treatment for complicated intra-abdominal infections and complicated urinary tract infections.
The variable race is associated with UTI in children, but it can be replaced with history of UTI and duration of fever in a previously developed prediction tool.
As of April 5, 2022, CDC Nowcast data reported that the BA.2 subvariant accounted for more than 50% of cases in all US states and territories.
Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales.
The phase 3 CERTAIN-1 study compared the efficacy and safety of cefepime-taniborbactam to meropenem in 661 adults with cUTI.
MV140 is a sublingual vaccine of whole-cell inactivated bacteria that may be an alternative to frequent antibiotics for recurrent urinary tract infections.
Researchers conducted a study to assess the effect of an antibiotic stewardship program on the use of appropriate antibiotic therapy among patients with urinary tract infections in the ED.
The application includes data from the phase 3 ADAPT-PO trial, which evaluated the efficacy and safety of tebipenem HBr in 868 adults with cUTI or acute pyelonephritis.
Researchers conducted a study to assess the safety and efficacy of aminoglycosides or polymyxin monotherapy for the treatment of adults with complicated urinary tract infections caused by extensively drug-resistant
Researchers sought to determine whether an intervention to improve the knowledge and communication skills of nursing care facility staff decreases the number of inappropriate antibiotic prescriptions for patients with suspected urinary tract infection.
Study finds that among women with uncomplicated urinary tract infection (UTI), those with antimicrobial-resistant isolates are at increased risk for progression to complicated UTI vs those with susceptible isolates.
Researchers conducted a crossover study to determine whether probenecid and cephalexin administered together increases the clinical benefits of cephalexin.
Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with cotrimoxazole vs fluoroquinolones.